Francesca Chiara Surace

Francesca Chiara Surace


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
GSGaia Spaziani
Gaia Spaziani
FGFrancesca Girolami
Francesca Girolami
LALuigi Arcieri
Luigi Arcieri
GCGiovanni Battista Calabri
Giovanni Battista Calabri
GPGiulio Porcedda
Giulio Porcedda
SFSilvia Favilli
Silvia Favilli
Bicuspid aortic valve (BAV) is the most common congenital heart defect. Prevalence of isolated BAV in the general pediatric population is about 0.8%, but it has been reported to be as high as 85% in patients with aortic coarctation. A genetic basis has been recognized, with great heterogeneity. Standard BAV terminology, recently proposed on the basis of morpho-functional assessment by transthoracic echocardiography, may be applied also to the pediatric population. Apart from neonatal stenotic BAV, progression of valve dysfunction and/or of the associated aortic dilation seems to be slow during pediatric age and complications are reported to be much rarer in comparison with adults. When required, because of severe BAV dysfunction, surgery is most often the therapeutic choice; however, the ideal initial approach to treat severe aortic stenosis in children or adolescents is not completely defined yet, and a percutaneous approach may be considered in selected cases as a palliative option in order to postpone surgery. A comprehensive and tailored evaluation is needed to define the right intervals for cardiologic evaluation, indications for sport activity and the right timing for intervention.

22 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
RMRoberto Manfredi
Roberto Manfredi
Francesco BiancoFrancesco Bianco
Francesco Bianco
VBValentina Bucciarelli
Valentina Bucciarelli
GCGiuseppe Ciliberti
Giuseppe Ciliberti
FGFederico Guerra
Federico Guerra
MPMarco Pozzi
Marco Pozzi
Messenger RNA (mRNA) coronavirus disease of 2019 (COVID-19) vaccines have been recently associated with acute myocarditis, predominantly in healthy young males. Out of 231,989 vaccines administrated in our region (Marche, Italy), we report a case series of six healthy patients (four males and two females, 16.5 years old (Q1, Q3: 15, 18)) that experienced mRNA-COVID-19-vaccines side effects. All patients were hospitalized due to fever and troponins elevation following the second dose of an mRNA-based COVID-19 vaccine. Cardiovascular magnetic resonance (CMR) was performed 72–96 h after vaccination. All patients were treated with colchicine and ibuprofen. Myocarditis was prevalent in males. It was characterized by myocardial edema and late gadolinium enhancement (LGE) in the lateral wall of the left ventricle (LV). One patient showed sole right ventricular involvement, while the females presented with myopericarditis (myocarditis + pericardial effusion). All patients in our series had preserved LV ejection fraction and remained clinically stable during a relatively short inpatient hospital stay. One case presented with atrial tachycardia. At the follow-up, no significant CMR findings were documented after a three-month medical treatment. According to other recently published case series, our report suggests a possible association between acute myocarditis and myopericarditis with mRNA COVID-19 vaccination in healthy young adults and pediatric patients. Not only males are involved, while some arrhythmic manifestations are possible, such as atrial tachycardia. Conversely, we here highlight the benign nature of such complications and the absence of CMR findings after a three-month medical treatment with colchicine and ibuprofen.

4 January 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
GSGaia Spaziani
Gaia Spaziani
FSFrancesca Chiara Surace
Francesca Chiara Surace
FGFrancesca Girolami
Francesca Girolami
Francesco BiancoFrancesco Bianco
Francesco Bianco
VBValentina Bucciarelli
Valentina Bucciarelli
SFSilvia Favilli
Silvia Favilli
Advances in both imaging techniques and genetics have led to the recognition of a wide variety of aortic anomalies that can be grouped under the term ‘hereditary thoracic aortic diseases’. The present review aims to summarize this very heterogeneous population’s clinical, genetic, and imaging characteristics and to discuss the implications of the diagnosis for clinical counselling (on sports activity or pregnancy), medical therapies and surgical management.